Integrated Quantitative Investments’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
37,396
+2,475
+7% +$104K 0.19% 192
2026
Q1
$1.93M Sell
34,921
-3,125
-8% -$149K 0.35% 78
2025
Q4
$1.42M Buy
38,046
+5,576
+17% +$226K 0.31% 110
2025
Q3
$1.31M Sell
32,470
-16,361
-34% -$540K 0.37% 68
2025
Q2
$1.25M Sell
48,831
-46
-0.1% -$1K 0.37% 74
2025
Q1
$1.04M Sell
48,877
-64
-0.1% -$1.43K 0.51% 62
2024
Q4
$1.03M Buy
+48,941
New +$1.13M 0.51% 71

Other funds holding PAHC

Integrated Quantitative Investments's PAHC Position: Q2 2026 in Review

Integrated Quantitative Investments increased its Phibro Animal Health (PAHC) stake by 7.1% in Q2 2026, buying an estimated $104K and bringing the position to 37,396 shares worth $1.17M. The position accounts for 0.19% of the portfolio, ranked #192.

Integrated Quantitative Investments first reported a position in PAHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.93M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Integrated Quantitative Investments held 37,396 shares of Phibro Animal Health worth $1.17M as of Q2 2026.
  • Integrated Quantitative Investments bought 2,475 Phibro Animal Health shares in Q2 2026, an estimated $104K.
  • Phibro Animal Health made up 0.19% of Integrated Quantitative Investments's portfolio in Q2 2026, its #192 holding.
  • Integrated Quantitative Investments first reported a position in Phibro Animal Health in Q4 2024 and has held it in 7 quarters since.
  • Integrated Quantitative Investments's Phibro Animal Health position peaked at $1.93M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.